Yangguang Nuohe signed a contract with Huawei Cloud to jointly build a large-scale platform for peptide molecules.

On May 13, Beijing Sunlight Nuohuo Pharmaceutical Research Co., Ltd. announced that its wholly-owned subsidiary Guangdong Nuohuo Intelligent Peptide Biotechnology Co., Ltd. has officially signed a contract with Huawei Cloud Computing Technology Co., Ltd. The two parties will jointly build a "peptide molecule large model platform" based on Huawei Cloud Panggu technology.